Company intelligence / Profile preview

OnPoint Vision

Aliso Viejo, California, United Statesonpoint-vision.com ↗
Ownership
Private
Employees
~20
Development stage
Other
01

Overview

The company’s AccuraSee intraocular lens has completed an early feasibility study in post-cataract patients and received FDA approval for a Phase I trial targeting age-related macular degeneration. The product aims to restore or improve vision in patients with significant visual impairment after cataract surgery or due to AMD. A larger multi-site clinical study with up to 350 patients was planned as of late 2023.

Therapeutic areas
Ophthalmology
Modalities
Device (Intraocular lens)
Industry
Implantable Medical Devices
02

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed. There may be potential future collaborations with companies developing drugs for AMD, as referenced by the founder regarding possible synergy with Apellis Pharmaceuticals’ approved drug for AMD

Beyond the preview

Go deeper on OnPoint Vision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OnPoint Vision.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call